REACHOUT Mental Health Support App for Type 1 Diabetes

Recruiting in Palo Alto (17 mi)

Overseen ByTricia S Tang, PhD

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of British Columbia

No Placebo Group

Trial Summary

What is the purpose of this trial?This trial investigates the effectiveness of the REACHOUT app, which offers mental health support to adults with type 1 diabetes through peer interactions and virtual meetings. The app includes personalized peer support, a 24/7 chat room, and virtual educational sessions. It aims to provide emotional and practical help to those managing type 1 diabetes.

Eligibility Criteria

This trial is for adults over 19 with type 1 diabetes who live in certain areas of British Columbia, speak English, and experience some distress related to their diabetes. They must have internet or smartphone access. Those with pre-existing mental health conditions or substance use issues cannot participate.

Inclusion Criteria

I have type 1 diabetes.

I am 19 years old or older.

Participant Groups

The study tests a mobile app called REACHOUT that offers peer-led mental health support to adults with type 1 diabetes. Participants will use the app's features like chat rooms and virtual happy hours for six months, compared to a wait-list group.

2Treatment groups

Experimental Treatment

Active Control

Group I: REACHOUTExperimental Treatment1 Intervention

The REACHOUT intervention arm will receive access to the REACHOUT mobile app through which they will be able to review profiles of Peer Supporters and connect with one of their choosing. They will also have access to the other app features including a 24/7 chat room and face-to-face support via virtual happy hours. Participants will complete questionnaires (baseline, 1 month, 3 months, 6 months) and a blood draw (baseline and 6 months). Monetary compensation will be provided for their time and effort.

Group II: Wait-listActive Control1 Intervention

The wait-list control group will receive access to the mobile app/support program after six (6) months. They will complete questionnaires and a blood draw at baseline and 6 months. Monetary compensation will be provided for their time and effort.